Dr Martin Deahl, 58, from Newport, Shropshire…
“I trained with Pauline in York before we flew out to Sierra Leone.
“We flew out on November 23 for five weeks along with 29 NHS volunteers.
“I worked in Port Loko with most of the volunteers and Pauline went to Kerry Town with three or four others
“We all met up again at Free Town on Saturday night for a reunion. We all got very close to each other and there would have been lots of contact with Pauline.
“On Sunday we flew into Casablanca and had a six hour stop-over in the airport lounge. Again there was lots of us hugging and chatting with each other…”
– Pauline Cafferkey and Dr Martin Deahl flew with NHS volunteers
– 29 NHS volunteers
– 5 weeks to Sierra Leone
– Only Pauline Cafferkey tested positive and is being treated for Ebola
– Unknown (secret) investigative drug being trialled
– Blood Plasma trialled on Ms Cafferkey
– No further details of other supportive recovery care.
Prof Jonathan Ball, Professor of Molecular Virology, University of Nottingham, said: “This is really good news – the team at the Royal Free have done a fantastic job.
“We will never know if investigational drugs and convalescent plasmas contributed to her improvement, but it does once again highlight the huge benefits that modern well-resourced critical care interventions can bring to those suffering from severe Ebolavirus infection.”
Investigational drugs? Trial drugs?
Dr Jacobs said: ‘At the moment, we don’t know what the best treatment strategies are. That’s why we’re calling them experimental treatments.
What have these people being doing in West Africa for the past 3 months? They still do NOT know what supportive therapies increase survival rates? What protocols was Ms Cafferkey using with West African ebola patients?
It is quite an admission, that despite the involvement of MSF, UN, USAID, US Army, UK Army, etc they have not determined a clear recovery protocol and still wait for a pre-infection solution – vaccine.
This blogger recommends they try the alternative solutions mentioned on this blog, they will at least cause no further harm unlike the “experimental” vaccines and GMO drugs.
Dr. Martin Salia, 44, who arrived Saturday from West Africa in dire health, was pronounced dead Monday morning from the virus. He reportedly tested negative for the virus despite having been in the throes of infection.
The Washington Post reported the following:
Salia was treated with the blood of an Ebola survivor as well as the experimental treatment ZMapp, which was initiated on Saturday, the hospital said. When he arrived in Nebraska on Saturday, he was already suffering from kidney and respiratory failure. He died at about 4 a.m. local time, according to the hospital.